ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,058Medicare Part D Prescriptions Filled, Including Refills

Rank: 658 out of 2888

$550K Total Retail Price of All Prescriptions

Rank: 724 out of 2888

606 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 8,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 629 594 1 2
LEVOTHYROXINE SODIUM 587 569 2 1
LISINOPRIL 507 469 3 3
OMEPRAZOLE 360 335 4 7
HYDROCODONE-ACETAMINOPHEN 277 265 S3 5 4
AMLODIPINE BESYLATE 258 255 6 5
ZOLPIDEM TARTRATE 223 217 7 17
HYDROCHLOROTHIAZIDE 193 190 8 15
ALENDRONATE SODIUM 192 184 9 23
FLUTICASONE PROPIONATE 189 179 10 32
METOPROLOL SUCCINATE 180 176 11 11
CITALOPRAM HBR 174 169 12 24
LOSARTAN POTASSIUM 171 161 13 18
METFORMIN HCL 154 142 14 8
ATORVASTATIN CALCIUM 150 135 15 9
FUROSEMIDE 142 133 16 6
ETODOLAC 121 105 17 170
CIPROFLOXACIN HCL 118 112 18 47
METOPROLOL TARTRATE 113 105 19 10
ATENOLOL 110 109 20 25
DIOVAN 110 100 20 35
CARVEDILOL 101 101 22 21
WARFARIN SODIUM 94 77 23 22
POTASSIUM CHLORIDE 85 78 24 14
GABAPENTIN 80 67 25 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 60 26 28
ZETIA 72 67 26 81
PRAVASTATIN SODIUM 71 67 28 12
NEXIUM 69 63 29 19
SPIRIVA 68 60 30 79
CRESTOR 67 66 31 20
FLUOXETINE HCL 66 52 32 83
AMLODIPINE BESYLATE-BENAZEPRIL 66 66 32 67
GLIMEPIRIDE 65 61 34 36
QUINAPRIL HCL 65 65 34 179
ZOSTAVAX 59 52 36 221
BUPROPION XL 59 55 36 212
TIZANIDINE HCL 59 59 36 133
ESTRADIOL 58 56 R 39 139
TRIAMTERENE-HCTZ 55 55 40 63
PANTOPRAZOLE SODIUM 53 51 41 33
SERTRALINE HCL 52 51 42 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.